To reduce unnecessary prostate biopsies, these clinical indicators, including age, prostate volume (PV), PSA density (PSAD), and free to total PSA ratio (f/t-PSA), were used to improve the ability of PCa detection, especially in the PSA range of 4-20 ng/mL. The gene discussed is KLK3; the disease is posterior cortical atrophy.